Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone?

被引:22
作者
Algra, A
Van Gijn, J
Algra, A
Koudstaal, PJ
机构
[1] Univ Utrecht Hosp, Julius Ctr Patient Oriented Res, Dept Neurol, NL-3508 GA Utrecht, Netherlands
[2] Univ Rotterdam Hosp, Dept Neurol, Rotterdam, Netherlands
[3] Univ Utrecht Hosp, Dept Neurol, Utrecht, Netherlands
关键词
D O I
10.1136/jnnp.66.5.557
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:557 / 559
页数:3
相关论文
共 22 条
  • [1] Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia
    Algra, A
    vanGijn, J
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (02) : 197 - 199
  • [2] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [3] *AM CAN COOP STUD, 1983, STROKE, V16, P406
  • [4] AICLA CONTROLLED TRIAL OF ASPIRIN AND DIPYRIDAMOLE IN THE SECONDARY PREVENTION OF ATHERO-THROMBOTIC CEREBRAL-ISCHEMIA
    BOUSSER, MG
    ESCHWEGE, E
    HAGUENAU, M
    LEFAUCCONNIER, JM
    THIBULT, N
    TOUBOUL, D
    TOUBOUL, PJ
    [J]. STROKE, 1983, 14 (01) : 5 - 14
  • [5] PLACING TRIALS IN CONTEXT USING BAYESIAN-ANALYSIS - GUSTO REVISITED BY REVEREND BAYES
    BROPHY, JM
    JOSEPH, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (11): : 871 - 875
  • [6] European stroke prevention study .2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
    Diener, HC
    Cunha, L
    Forbes, C
    Sivenius, J
    Smets, P
    Lowenthal, A
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 143 (1-2) : 1 - 13
  • [7] FITZGERALD GA, 1987, NEW ENGL J MED, V316, P1247
  • [8] Franke CL, 1997, ANN NEUROL, V42, P857
  • [9] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
    Gent, M
    Beaumont, D
    Blanchard, J
    Bousser, MG
    Coffman, J
    Easton, JD
    Hampton, JR
    Harker, LA
    Janzon, L
    Kusmierek, JJE
    Panak, E
    Roberts, RS
    Shannon, JS
    Sicurella, J
    Tognoni, G
    Topol, EJ
    Verstraete, M
    Warlow, C
    [J]. LANCET, 1996, 348 (9038) : 1329 - 1339
  • [10] GUIRAUDCHAUMEIL B, 1982, REV NEUROL, V138, P367